Purchase Order 75N91024P00560
Award Date 7/8/24
Potential Completion Date 7/7/25
Potential Value $11K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Bethesda, MD 20892, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a $6,178,859.14 federal contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the U.S. Department of Health and Human Services, to Duke University. The contract is for a "NONHUMAN PRIMATE CORE VIROLOGY LABORATORY FOR AIDS VACCINE RESEARCH AND DEVELOPMENT". This is a definitive, cost-no-fee contract with a period of performance through December 14, 2024. The contract was awarded on December 22, 2017 and does not have a set-aside...
- The National Institute of Allergy and Infectious Diseases awarded a $33.45 million definitive contract to Duke University for virology quality assurance on June 21, 2026, under no set-aside with a cost–no–fee pricing structure and performance through June 20, 2033. The originating solicitation sought a comprehensive quality assessment program for virologic assays for HIV and other viral pathogens, including procurement of quality control materials, provision of proficiency testing panels and...
- This is a delivery order awarded to Duke University under the Vaccine and Treatment Evaluation Units (VTEU) program, which is managed by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency. The $7,573,172.56 award is for consultation and testing of cytokine levels and cell activation in clinical samples. Duke University, a private research university, is the prime contractor for this cost-no-fee contract with a performance period ending on December 31, 2023....
- This is a federal contract award to Duke University by the National Institute of Allergy and Infectious Diseases (NIAID), which is part of the National Institutes of Health (NIH). The contract, valued at $10,236,804.91, is a Definitive Contract with a Cost Plus Fixed Fee pricing type. The contract does not have a set-aside designation. The contract is described as "TAS::75 0885::TAS", which likely refers to the task or service area, though the specific details are not provided. The...
- The National Institute of Allergy and Infectious Diseases awarded a $1.876 million cost-no-fee definitive contract to Duke University for operation of a Virology Core Laboratory, effective December 15, 2024, with completion December 14, 2031. The contract calls for measurement of viral RNA levels in samples, production of large volumes of viral stocks, development and optimization of assays to determine viral RNA levels in various samples, management and reporting of assay data, maintenance of...
- The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $28.34 million cost-reimbursement contract to Duke University's Office of Research Administration to establish and operate the Nonhuman Primate Core Humoral Immunology Laboratory for AIDS Vaccine Research and Development. The contract, awarded on March 30, 2025, with performance through March 29, 2032, supports critical vaccine development initiatives by providing specialized laboratory services to evaluate humoral...
- Duke University has been awarded a cost-no-fee task order valued at $10.38 million by the National Institutes of Health National Institute of Allergy and Infectious Diseases. The task order was issued against Duke University's existing preclinical and translational vaccine development IDIQ with the agency. Under this task order, Duke University will provide services and materials to support in vitro transcription reactions, mRNA purification, and procurement of lipid raw materials for...
- This federal contract award to Duke University was issued by the National Institute of Allergy and Infectious Diseases (NIAID), which is part of the National Institutes of Health (NIH), a civilian agency. The $13,368,236.91 definitive contract is for an "IMMUNOLOGY QUALITY ASSESSMENT PROGRAM" and does not have a set-aside designation. Duke University's Office of Research Administration Division is the prime contractor, and the contract has a period of performance ending on September...
- This federal contract award was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Duke University for the production of a protein called A. CON-ENV-03 140CF. The contract has a firm fixed price of $149,839.00 and was awarded on May 10, 2012, with a completion date of June 8, 2012. The contract was not set aside for any specific socioeconomic designation. Duke University, through its Office of Research...
- The National Institute of Allergy and Infectious Diseases awarded a definitive contract to Duke University for a nonhuman primate core humoral immunology laboratory supporting AIDS vaccine research and development, with a ceiling value of $19.8 million. The award was made on March 28, 2018, with an ultimate completion date of March 29, 2025. No set-aside was used. Place of performance is Durham, NC. The contract operates under cost-no-fee pricing. Service Contract Inventory reporting shows...